Clinical Trials Browser

Phase NA × aumolertinib × CNS × Clear all

NCT04778800 2021-08-31

A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)

Phase NA Unknown

Brain Neoplasms, Meningeal Carcinomatosis

NCT04944069 2021-06-29

ATTRACT

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis